Jeff Yastine Explains The Importance Of Regtech Companies For The Future

According to Jeff Yastine it is always possible to tell when bureaucrats become involved in an industry. A Chief Compliance Officer is required for every company, and lieutenants make up an entire department to comply with the newest diktat. Whether the added rules make the situation worse or better is a debate. One thing not debatable is the additional rules drag the prices of a company’s stock and increase costs. The exception is regulatory technology or regtech. Regtech is employing tools such as blockchain technology, artificial intelligence or advanced software to pursue the decrease of regulatory costs.

Eighty companies were identified as emerging regtechs last year by Bain & Co. Their names are unfamiliar, and most are still close to the startup stage. These companies are destined to show substantial growth according to Global banks spend roughly $70 billion in ensuring compliance with the jurisdictions and rules in business. In the next three-years, the figure is expected to increase to $120 billion. It can take over two-years and ten million to fulfill regulations with computer systems. A regtech specialist can accomplish the same thing for $300,000 in three months. In Europe, the estimation for banks to comply with EU’s financial regulations costs more than $1 billion.


The regulators have noticed the regtech companies, and brought them into their ecosystem. The Bank of England is the monetary authority for Singapore, and along with the Office of the Comptroller, or the OCC, have made propositions regarding regtech companies. The OCC proposed last year some regtech companies can provide federal pre-emption due to their access to the national bank charter according to Attention should be given to these companies regarding investment considerations since they have already been given a seat at the proverbial table.

Jeff Yastine currently works for the Total Wealth Insider as their editor. His career with Banyan Hill Publishing began in 2015 as the editorial director. He brought over twenty years of experience to the company due to his work as a financial journalist and an investor in the stock market. He helps investors grasp business monetary and economic trends with his contributions to the Winning Investor Daily, and the Sovereign Investor Daily each week.

Find more about Jeff Yastine:

Madison Street Capital: The Leading Investment Banking Firm

Madison Street Capital is a globally recognized firm in investment banking. Madison Capital provides quite a number of services to its clients. It provides financial services in advisory, valuation services, financial opinions and acquisition expertise to its wide range of clients both in the public and private sectors. Madison Street Capital’s team of professionals has specialized expertise in the middle market firms enabling them to analyze each client’s options while providing optimum results.

Investment banking is concerned with the ultimate aim of assisting individuals and companies in the capital markets. Generally investment bankers are in the business of helping and facilitating agencies, governments and companies through the selling and issuance of securities in the stock market. Investment banking plays a very critical functions that include financial, strategic and advisory roles. Investment banking mainly deals in IPOs, shares and mutual funds to raise their capital.

Madison Street Capital Advisors LLC was founded in the year 2011 and incorporated in Illinois. It is a privately held company. In the year 2015 Madison Street Capital managed to close 42 hedge fund deals. This was a slight increase from what was posted in the year 2014 where they managed to announce the closing of 32 deals in the hedge fund industry. Madison Capital has admitted that in 2015 the market was fair. They have also foreseen a great deal market environment in the year 2016 going by the market trends in the hedge fund industry and generally in investment banking.

Having been in the investment banking for a long period, Madison Street Capital has gained a lot of experience in the industry. It has assisted a lot of clients in a diverse range of investment opportunities. Each of its client’s needs is made through careful analysis of the market and provision of practicable recommendations that spur growth. Madison’s primary concern is their client’s satisfaction.

Madison Street Capital has a group of professionals who have a vast wealth of experience and expertise in the investment banking industry making it one of the premiere and pioneer institutions in the world in middle market investment banking. With its headquarters in Chicago, Illinois the middle investment banking firm has other satellite offices across three continents namely Africa, Asia and North America.

The investment giant is also involved in quite a number of philanthropic activities. It supports organizations that are focused in bringing the desired change in the society and community at large.

For corporations and companies, investment banking helps them raise capital through facilitating of trading of securities which in the end increase liquidity in the securities that will be traded. For individuals investment banking provides them with investment opportunities. Subsequently for corporations investment banking provides advisory opinions regarding mergers, acquisitions and other business ventures that the corporations wish to undertake.

Follow Madison on Facebook

U.S. Patent Trial and Appeal Boards Accepts Kyle Bass Petition

Kyle Bass is a hedge fund owner who has also founded the Coalition for Affordable Drugs (CFAD). The Coalition filed a petition with the Patient Trial and Appeal Board (PTAB) for an inter partes review (IPR) of a patent owned by the pharmaceutical firm Biogen (NASDAQ:BIIB). That means the United States Patent and Trademark Office (USPTO) agreed that the Coalition demonstrated there was a reasonable likelihood it could prove the patent was not viable. The final decision will take about a year.

Bass’s Coalition challenged U.S. Patent No. 8,399,514, which is using 480 milligrams of dimethyl fumarate for treating multiple sclerosis. It is scheduled to expire in 2028.

The current petition is the second filed against the same patent by the Coalition for Affordable Drugs. Last year, the PTAB denied the Coalition’s petition. It says it found the current petition much more persuasive.

The patent has another challenge that’s still pending. Last year, Forward Pharma A/S (NASDAQ:FWP) filed a challenge on its own behalf. The PTAB declared the patent had interference. The PTAB wants Biogen to prove it came up with the technology first, and not Foward. That case is scheduled to be heard in January 2017.

In the European Union, the same technology was protected by EU Patent No. EP2137537. However, Forward and a few other parties filed a challenge to that patent, and the European Patent Office has revoked it. Biogen is appealing that decision.

CFAD has filed petitions challenging other pharmaceutical drug patents owned by other drug companies, including Jazz Pharmaceuticals plc, Acorda Therapeutics Inc and Celgene Corporation.

The CFAD has filed 33 IPR petitions with the U.S. Patent Office challenging drug patents. So far, the PTAB has issued decisions on 17 of those 33 petitions. Of those 17, the PTAB has denied 10 petitions and allowed 7.

Kyle Bass is the owner of Hayman Capital Management L.P, a hedge fund. He is well-known for profiting enormously from the subprime mortgage crisis in 2008. He purchased credit default swaps in many of the securities issued by investment funds, which means he made money when their price went down, similarly to shorting them. When the true weakness of those securitized mortgages was widely publicized, Bass made about half a billion dollars, while the investment banks were bought up or went out of business.

What Entails Investment Banking and Martin Lustgarten

Investment banking is part of the bigger normal banking industry. It specializes in assisting and helping companies, individuals and corporations acquire financial capital. In addition to this, investment banking involves mergers and acquisitions, trade and issuing of financial securities, underwriting debts and provision of advisory services on issuance of stock. Investment banking is one of the booming business ventures if one has the correct expertise and knowledge.

Investment bankers are key professionals in any investment bank. This is because, they have the necessary expertise to handle complex financial transactions that involve a lot of finances, they assist banks in coming up with deals that are best suited for their clients. Hedge Funds are major clients of investment banks since they deal with huge amounts of finances. Investment banks are the pass throughs when companies are issuing new stock and bonds into the market. They will help in connecting any investor with the particular company and help both parties come up with a win-win deal.

This can be made possible if an investment bank has good analysts who are able to predict the performance of stocks and shares.

Lustgarten is an investment banking firm based in Miami, Florida and carries out its operations in Florida and the United States. Lustgarten’s CEO and founder is Martin Lustgarten. During his career, he has managed to handle and facilitate some of the best deals in Florida. He has made Lustgarten to be a well-known investment bank with a wide pool of clients. He is very friendly towards his clients and he always seeks to offer the best whenever he is approached. This has led to him described as among the best investment bankers.

Martin enjoys collecting vintage trophies which he occasionally does during his free time. He is also described as a vintage watch trader. He is a philanthropist and he gives his support to charity initiatives through GoFundMe. Martin is active on social media which he seeks to update as many times as he can.